Larvol Delta - Acumen-Pharmaceuticals-Announces-Topline-Results-from-Phase-1-Study-of-Subcutaneous-Formulation-of-Sabirnetug-in-Healthy-Volunteers

sabirnetug IV (ACU193 IV) - Acumen Pharma

sabirnetug SC (ACU193 SC) - Acumen Pharma

https://www.globenewswire.com/news-release/2025/03/19/3045315/0/en/Acumen-Pharmaceuticals-Announces-Topline-Results-from-Phase-1-Study-of-Subcutaneous-Formulation-of-Sabirnetug-in-Healthy-Volunteers.html

Mar 19, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next